Consolidated Balance Sheets (USD $)	Mar. 31, 2012	Dec. 31, 2011
CURRENT ASSETS
Cash and cash equivalents	$ 19,793	$ 53,573
Accounts receivable, net of allowance of $0 at March 31, 2012 and December 31, 2011	3,060
Inventory	33,101	35,137
Deferred finance charges	9,313	13,625
Prepaid expenses	87,382	117,760
TOTAL CURRENT ASSETS	152,649	220,095
PROPERTY AND EQUIPMENT
Capital equipment	32,604	32,604
Less accumulated depreciation	32,604	32,604
Patent costs, net of accumulated amoritization of $81,619 and $78,851 as of March 31, 2012 and December 31, 2011	115,850	118,618
TOTAL ASSETS	268,499	338,713
CURRENT LIABILITIES
Accounts payable and accrued expenses	1,748,005	1,583,853
Notes payable	50,000	50,000
TOTAL CURRENT LIABILITIES	1,798,005	1,633,853
LONG-TERM LIABILITIES
Senior secured convertible notes payable	781,500	781,500
Convertible notes payable	140,000	140,000
Notes payable, net of discount of $17,350 and $18,589 as of March 31, 2012 and December 31, 2011	1,093,650	1,092,411
TOTAL LONG-TERM LIABILITIES	2,015,150	2,013,911
STOCKHOLDERS' DEFICIT
Preferred Stock, $ .001 par value; 75,000,000 shares authorized; no shares issued and outstanding
Common stock, $ .001 par value; 175,000,000 shares authorized; 174,940,506 shares issued and 145,144,603 outstanding at March 31, 2012 and December 31, 2011	174,940	174,940
Additional paid in capital	8,817,382	8,817,382
Treasury stock (29,795,903 shares at March 31, 2012 and December 31, 2011), at cost	(113,389)	(113,389)
Deficit accumulated during the development stage	(12,423,589)	(12,187,984)
STOCKHOLDERS' DEFICIT	(3,544,656)	(3,309,051)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 268,499	$ 338,713